Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
IUBMB Life
|
November 12, 2020
Mitochondria and nucleus cross-talk: Signaling in metabolism, apoptosis, and differentiation, and function in cancer
Anna Shteinfer-Kuzmine, Ankit Verma, Tasleem Arif, et al.
Oncotarget
|
April 17, 2017
Mitochondrial VDAC1-based peptides: Attacking oncogenic properties in glioblastoma
Anna Shteinfer-Kuzmine, Tasleem Arif, Yakov Krelin, et al.
Cancers
|
March 11, 2023
Pro-Apoptotic and Anti-Cancer Activity of the Vernonanthura Nudiflora Hydroethanolic Extract
Almog Nadir, Anna Shteinfer-Kuzmine, Swaroop Kumar Pandey, et al.
Molecular Oncology
|
April 1, 2021
SMAC/Diablo controls proliferation of cancer cells by regulating phosphatidylethanolamine synthesis
Swaroop Kumar Pandey, Avijit Paul, Anna Shteinfer-Kuzmine, et al.
Biomolecules
|
January 28, 2026
p53 Interacts with VDAC1, Modulating Its Expression Level and Oligomeric State to Activate Apoptosis
Elinor Gigi, Aditya Karunanithi Nivedita, Danya Ben-Hail, et al.
Molecular Therapy. Oncology
|
February 2, 2026
Survivin/BIRC5-derived peptide disrupts survivin dimerization and cell division and induces multifaceted anti-cancer effects
Manikandan Santhanam, Venkatadri Babu, Anna Shteinfer-Kuzmine, et al.
Molecular Therapy. Oncology
|
February 9, 2026
Erratum: Survivin/BIRC5-derived peptide disrupts survivin dimerization and cell division and induces multifaceted anti-cancer effects
Manikandan Santhanam, Venkatadri Babu, Anna Shteinfer-Kuzmine, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 7, 2024
Interaction of SMAC with a survivin-derived peptide alters essential cancer hallmarks: Tumor growth, inflammation, and immunosuppression
Manikandan Santhanam, Swaroop Kumar Pandey, Anna Shteinfer-Kuzmine, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 4, 2021
The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target
Ankit Verma, Srinivas Pittala, Belal Alhozeel, et al.
The Journal of Biological Chemistry
|
October 15, 2016
Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect against Mitochondrial Dysfunction
Danya Ben-Hail, Racheli Begas-Shvartz, Moran Shalev, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
IUBMB Life
|
November 12, 2020
Mitochondria and nucleus cross-talk: Signaling in metabolism, apoptosis, and differentiation, and function in cancer
Anna Shteinfer-Kuzmine, Ankit Verma, Tasleem Arif, et al.
Oncotarget
|
April 17, 2017
Mitochondrial VDAC1-based peptides: Attacking oncogenic properties in glioblastoma
Anna Shteinfer-Kuzmine, Tasleem Arif, Yakov Krelin, et al.
Cancers
|
March 11, 2023
Pro-Apoptotic and Anti-Cancer Activity of the Vernonanthura Nudiflora Hydroethanolic Extract
Almog Nadir, Anna Shteinfer-Kuzmine, Swaroop Kumar Pandey, et al.
Molecular Oncology
|
April 1, 2021
SMAC/Diablo controls proliferation of cancer cells by regulating phosphatidylethanolamine synthesis
Swaroop Kumar Pandey, Avijit Paul, Anna Shteinfer-Kuzmine, et al.
Biomolecules
|
January 28, 2026
p53 Interacts with VDAC1, Modulating Its Expression Level and Oligomeric State to Activate Apoptosis
Elinor Gigi, Aditya Karunanithi Nivedita, Danya Ben-Hail, et al.
Molecular Therapy. Oncology
|
February 2, 2026
Survivin/BIRC5-derived peptide disrupts survivin dimerization and cell division and induces multifaceted anti-cancer effects
Manikandan Santhanam, Venkatadri Babu, Anna Shteinfer-Kuzmine, et al.
Molecular Therapy. Oncology
|
February 9, 2026
Erratum: Survivin/BIRC5-derived peptide disrupts survivin dimerization and cell division and induces multifaceted anti-cancer effects
Manikandan Santhanam, Venkatadri Babu, Anna Shteinfer-Kuzmine, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 7, 2024
Interaction of SMAC with a survivin-derived peptide alters essential cancer hallmarks: Tumor growth, inflammation, and immunosuppression
Manikandan Santhanam, Swaroop Kumar Pandey, Anna Shteinfer-Kuzmine, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 4, 2021
The role of the mitochondrial protein VDAC1 in inflammatory bowel disease: a potential therapeutic target
Ankit Verma, Srinivas Pittala, Belal Alhozeel, et al.
The Journal of Biological Chemistry
|
October 15, 2016
Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect against Mitochondrial Dysfunction
Danya Ben-Hail, Racheli Begas-Shvartz, Moran Shalev, et al.
Page
of 4